Figure 1

Amplification plots of the real-time PCR for β-actin in plasma DNA from non-small cell lung cancer patients and healthy controls. The relative amount of plasma DNA is higher in patient samples compared with controls.
Amplification plots of the real-time PCR for β-actin in plasma DNA from non-small cell lung cancer patients and healthy controls. The relative amount of plasma DNA is higher in patient samples compared with controls.